Panel recommends FDA reject MDMA as treatment for PTSD
An advisory committee is evaluating the evidence supporting MDMA-assisted therapy as a treatment for post-traumatic stress disorder.
View original article
Contributor: Daniel Gilbert, David Ovalle
